Scholar Rock, Inc.
Clinical trials sponsored by Scholar Rock, Inc., explained in plain language.
-
New drug aims to preserve muscle during weight loss in obesity trial
Disease control CompletedThis study tested a drug called apitegromab in 102 overweight or obese adults who were also taking a GLP-1 medication (like Ozempic or Wegovy). The goal was to see if adding apitegromab helps preserve lean muscle mass while losing weight. Participants received either the drug or …
Phase: PHASE2 • Sponsor: Scholar Rock, Inc. • Aim: Disease control
Last updated May 17, 2026 09:19 UTC
-
New drug shows promise for muscle strength in SMA patients on standard therapy
Disease control CompletedThis study tested a drug called apitegromab in 188 people aged 2 to 21 with later-onset spinal muscular atrophy (SMA types 2 and 3) who were already taking nusinersen or risdiplam. The goal was to see if adding apitegromab could improve muscle function more than a placebo. Partic…
Phase: PHASE3 • Sponsor: Scholar Rock, Inc. • Aim: Disease control
Last updated May 14, 2026 12:05 UTC